Evaluation of Antiplasmodial activity of extracts and constituents from Ampelozizyphus amazonicus by do Carmo, Dominique F M et al.
5/11/2018 Evaluation of Antiplasmodial activity of extracts and constituents from Ampelozizyphus amazonicus
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653334/?report=printable 1/11
Go to:




Evaluation of Antiplasmodial activity of extracts and constituents from
Ampelozizyphus amazonicus
Dominique F. M. do Carmo, Ana Claudia F. Amaral,  Marta Machado,  Dinora Lopes,  Aurea Echevarria,
Virgílio E. Rosário,  and Jefferson Rocha de A. Silva
Department of Chemistry, Chromatography Laboratory, Federal University of Amazonas (UFAM), Rodrigo Otavio Avenue, 3000, Academic
Campus, 69077-000, Manaus, Amazonas, Brazil
Department of Natural Products, Medicinal Plants and Derivatives Laboratory, Farmanguinhos, Oswaldo Cruz Foundation (FIOCRUZ),
Sizenando Nabuco Street, 100, Manguinhos, 21041-250, Brazil
Parasitology Unit, Center of Studies on Malaria and Other Tropical Diseases, LA, Institute Hygiene and Tropical Medicine from the New
University of Lisbon, Junqueira street, 100, 1349-008 Lisboa, Portugal, Brazil
Department of Chemistry, Federal Rural University of Rio de Janeiro (UFRRJ) Km 47, Seropedica, 23851970, Rio de Janeiro, RJ, Brazil
Address for correspondence: Dr. Jefferson Rocha de A. Silva, Department of Chemistry, Chromatography Laboratory, Federal University
of Amazonas (UFAM), Rodrigo Otavio Avenue, 3000, Academic Campus, 69077-000, Manaus, Amazonas, Brazil. E-mail:
jrocha_01@yahoo.com.br
Received 2014 Sep 25; Revised 2014 Nov 14; Accepted 2015 Sep 24.
Copyright : © Pharmacognosy Magazine
This is an open access article distributed under the terms of the Creative Commons Attribution NonCommercial ShareAlike 3.0 License,
which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are
licensed under the identical terms.
Abstract
Background:
Ampelozizyphus amazonicus Ducke, a plant that is widely used by the population of the Amazonian region
to prevent and treat malaria, was investigated in this work, which describes, for the first time, the
antiplasmodial activity of its extracts and associates this activity with its isolated constituents.
Methods:
Different extracts with solvents of increasing polarity (hexane, chloroform, ethanol, and water) were
obtained of the root bark. This procedure resulted in extracts that were characterized for their constituents.
The cytotoxicity and activity of the extracts against Plasmodium berghei (schizontocidal activity, liver
stage) and Plasmodium falciparum (3D7 and Dd2 strains, erythrocyte stage) were assessed in vitro.
Results:
Of the four extracts assayed against P. berghei, the chloroform extract showed the greatest activity, with an
inhibitory concentration 50% (IC ) value of 30.1 µg/mL, followed by the aqueous extract (IC  = 39.9
µg/mL). The chloroform extract exhibited the highest antiplasmodial activity in the erythrocyte stage of P.
falciparum, with an IC  value lower than 15 µg/mL. Fractionation of this more active extract led to the
isolation and elucidation of pentacyclic triterpenes, lupeol, betulin and betulinic acid, which showed
antiplasmodial activities with IC  values ranging from 5.6 to 80.30 µM. The most active of these,
betulinic acid, was further quantified in the extracts by high-performance liquid chromatography-
photodiode array detector analyzes. The higher amount was found in the chloroform extract, which was the
most active one against P. falciparum.
Conclusion:












The results obtained in this work may partly explain the popular intake of A. amazonicusas an antimalarial
remedy in the Amazon region.
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INTRODUCTION
Malaria is a major parasitic health problem in tropical and subtropical regions, caused by infection with
Plasmodium species and transmitted by Anopheles mosquitoes. It is endemic in 106 countries and is
responsible for about 216 million clinical cases and about 655,000 deaths in 2010.[1]
Five species of Plasmodium can cause human malaria: Plasmodium falciparum, Plasmodium vivax,
Plasmodium malariae, Plasmodium ovale and Plasmodium kwnolesi Cox-Singh; Singh. Of these, P.
falciparum is the most prevalent and lethal; when left untreated, it can lead to fatal malaria.[2] Until
recently, treatments against P. falciparum relied on chloroquine and sulfadoxine-pyrimethamine. However,
resistance to these drugs led the World Health Organization to recommend the use of artemisinin
combination therapy (ACT),[3] in which artemisinin derivatives, some new fast-acting antimalarial agents,
are used in combination with another antimalarial in order to reduce the chances of P. falciparum
becoming resistant to either drug. Unfortunately, clinical resistance to ACT has been reported in the
Cambodia-Thailand border region,[3,4] which suggests that P. falciparum parasites have already
developed the ability to grow in the presence of these antimalarials, and strongly indicates the need for
further research into new ones.[5]
Plants used in traditional medicine may offer a promising source of substances with antimalarial activity.
An approach to the identification of antimalarial drug candidates is to search for compounds from plants
that are used in folk medicine to prevent or cure malaria. Thus, it is worth documenting the ethnobotanical
information and testing the antiplasmodial activity of plant extracts. The species Ampelozizyphus
amazonicus Ducke is a strong candidate from the Amazon region. This species of the rhamnaceae family,
known locally as cerveja de índio (Indian beer), among other common names, is a hardy liana distributed
in South America and found in the Amazon region of Brazil, Venezuela, Colombia, Peru, and also
Ecuador. In Brazil, it is found in forests of the States of Amazonas, Pará, and Roraima.[6]
There are different preparations reported for this species;[7] the most widespread one is a mixture of A.
amazonicus root bark and water used as a preparation for malaria, and usually taken before bathing.[8]
This preparation acquires a yellow color and the appearance of frothy beer, but the foam is removed before
drinking. According to Oliveira et al. (2011),[7] A. amazonicus is able to prevent and treat malaria. Other
uses are attributed to this species, such as treatment of fever,[9] anti-inflammatory uses, and as an antidote
for snake venoms.[6]
In the last decade, some pharmacological studies have demonstrated the trypanocidal activity of the crude
extracts, fractions and isolated compounds of A. amazonicus stems against the trypomastigote forms of
Trypanosoma cruzi[10] and also the in vitro and in vivo prophylactic activity of the crude ethanol extract of
A. amazonicus roots against Plasmodium gallinaceum[8] and on preerythrocytic development of
Plasmodium berghei,[11] respectively. Furthermore, there are published reports of the diuretic activity of
the saponins mixture of the roots of this species,[12] showing an activity that had not been previously
reported. Although there have been some published reports about this species,[6] the active substances of
A. amazonicus have not yet been identified, and no reports exist on its activity against the erythrocytic
development of Plasmodium species/strains. Only crude extracts were tested and presented no activity in
the assay models used by the authors.[8]
A recent review describes the few phytochemical studies published on this species, which report the
presence of triterpenoids, steroids, and saponins.[6] The aim of this work is to evaluate the antiplasmodial
activity of the extracts obtained from A. amazonicus root barks, prepared according to their popular use,
and with solvents of different polarities, and the chromatographic fractionation of the most active ones.
The study includes assays against the liver stage of P. berghei and against the asexual blood stages in
chloroquine susceptible and resistant P. falciparum strains. It also describes the active constituents
associated with this activity and the quantification of betulinic acid in the extracts.
METHODS
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Chemical analysis
Nuclear magnetic resonance (NMR) spectra were run on a Bruker 400 or 500 MHz ( H: 400; 500 MHz;
C: 100; 125 MHz) spectrometer in solvents (CDCl  and CD OD) with chemical shifts reported in parts
per million relative to the residual solvent peaks.
Analytical high-performance liquid chromatography (HPLC) analysis was performed on a Shimadzu LC-8
Avp gradient chromatograph equipped with two LC-8Avp pumps, controlled by an interface module and
an automatic injector, and an SPD-M10 Avp photodiode array detector (PAD) was used for the peak purity
test and analysis of compounds. The solvents were filtered using a Millipore system, and chromatographic
separation was carried out on a C18 column (150 mm × 4.6 mm, 5 µm; Shimpack). HPLC grade solvents
and Milli-q water were used in this study, and all the chromatographic experiments were obtained under
isocratic conditions at room temperature.
Plant
The roots of A. amazonicus were collected in Ducke Reserve (Amazonas State, Brazil). A voucher
specimen (191532) is deposited at INPA (Instituto Nacional de Pesquisa da Amazônia), in the city of
Manaus, State of Amazonas, Brazil.
Extraction and isolation
The air dried root bark (250 g) of A. amazonicus was milled into a powder, and then extracted successively
with hexane, chloroform, and ethanol. The aqueous extract was prepared according to the popular use.[6]
The organic solvents were evaporated using a rotary evaporator, and the aqueous extract was lyophilized.
The active chloroform extract of the root bark (790 g) was submitted to flash chromatography, using silica
gel (70–230 mesh, 60 Å, Aldrich, 140 g) with hexane/ethyl acetate 9:1, hexane/ethyl acetate 3:7, ethyl
acetate 100% and MeOH 100% as eluents, yielding three fractions after thin layer chromatography
analysis. Among these fractions, the only active fraction (392 mg) was subjected to chromatography on
silica gel (230–400 mesh, Merck), and eluted with a step gradient of increasing ethyl acetate percentage in
hexane. This procedure resulted in compounds 1 (8.4 mg), 2 (187.6 mg), 3 (6.3 mg) and 4 (25.4 mg).
Lupeol (1) - Colorless needles (CH Cl  – hexane); mp = 211°C; identified by comparison with literature
data (mp, MS, H and C NMR, CDCl ).[13]
Betulinic acid (2) was crystallized from MeOH as white crystals (mp 297°C) and characterized by spectral
MS and NMR (CD OD) analyzes and comparison with the literature data.[14]
Betulin (3): White crystalline (CHCl ); mp 259°C. The identification was made by MS and NMR (CDCl )
analyzes and comparison with the literature data.[15]
Melaleucic acid (4) was crystallized from MeOH (white crystals, mp 320°C). The spectroscopic data NMR
(CD OD) were in accordance with the literature data.[16,17]
Quantification of betulinic acid by high-performance liquid chromatography
Analytical HPLC analysis was performed on a Shimadzu LC-8 Avp gradient chromatography system.
Stock solutions of hexane and chloroform extracts and isolated betulinic acid were prepared in methanol
and sonicated in an ultrasonic bath for 30 min. The final concentration of each sample was 1 mg/mL. An
aliquot of 20 µL was injected five times on the HPLC column (Shimadzu XR, ODS 50 mm × 2 mm, 5
µm), and the elution was carried out with water: Acetonitrile 30:70 (%, v/v) at a flow-rate of 1.0 mL/min.
The samples were monitored at 210 nm, and each concentration was injected five times. The calibration
solution contained this standard in the range of 15.62–1000 µg/mL. The curve was plotted using the area
average and betulinic acid concentration (µg/mL). All solvents were HPLC-UV grade (Tedia Brazil).
Linearity and detection limit
For the evaluation of the detection limit, a concentration sequence of betulinic acid was obtained by
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calculated based on three times of signal-to-noise ratio (S/N = 3). Solutions of betulinic acid, at five
different concentrations, were prepared to check the linearity, in the same volumetric flasks, using their
respective stock solutions. The calibration curves were drawn in the concentration range of 500–15.65
µg/mL. The spectrum was measured three times for each concentration. The equation for the calibration
curve was y = 3424x + 10340 and the correlation coefficient of the calibration plot was 0.999, indicating
good linearity.
Repeatability
One of the concentrations (250 µg/mL) was used to obtain repeatability. Intra-day and inter-day
repeatability experiments were conducted. The data used to calculate relative standard deviation (RSD) of
inter-day repeatability were the areas of four injections over a period of three days. The data for intra-day
repeatability were the areas of five injections on the same day. The RSD values were 3.19% for intra-day
and 1.47% for inter-day.
In vitro antimalarial liver stage assay
Female Balb/c strain mice weighting 20–25 g and the ANKA clone of P. berghei were used throughout the
experiments. To produce sporozoites, 4–7-day-old, nulliparous Anopheles stephensi (approximately 250
mosquitoes) were fed on gametocytemic mice and maintained thereafter at 21°C for 18–21 days. The
parasite infection status within the mosquito cages was monitored at day 8 by examining 5–10 mosquito
midguts for the presence of oocysts (infection ratio).
On the 19  day, the salivary glands were dissected for the detection and isolation of sporozoites and a
subsequent infection of Hep G2 cells. Briefly, HepG2 cells (15 × 10  cells/mL) were plated in eight-
chamber plastic Lab-Teck slides for 24 h prior to infection with 10 × 10  sporozoites/mL. The sporozoites
were freshly obtained through disruption of the salivary glands of infected female A. stephensi mosquitoes
and were added to each well. After 3 h at 37°C, the cultures were washed and further incubated with
extracts, for 48 h after infection. Primaquine was used as antimalarial control drug. The inhibition of
parasite development was measured through the immunofluorescent assay (IFA). Afterward, 48 h cells
were washed with PBS, fixed with methanol and incubated with a 100 µl mixture of monoclonal antibody
i72 (20 µl) and phosphate-buffered-saline (PBS) (980 µl) for 30 min to 1 h, in a humid chamber.[18] The
wells were then washed with 300 µl PBS and 100 µl mixture of GAMIg / FITC and PBS for another 30
min, under the same conditions; glass slides were prepared with a 1:1 glycerol/PBS solution. The number
of parasites was then determined by fluorescence microscopy. The dose-response curves of the drugs were
determined compared to control (without drug) preparation wells. The concentration that inhibits 50% of
parasite development (IC ) was determined by nonlinear regression analyzes using the GraphPad Prism
for windows version 5.01, GraphPad Software, Inc.
In vitro antimalarial activity in erythrocytic stages
Human malaria parasites were cultured as previously described by,[19] with minor modifications. Briefiy,
chloroquine-sensitive (3D7) and chloroquine resistant (Dd2) P. falciparum strains were maintained in
continuous cultures in fresh human erythrocyte in RPMI 1640 medium (Gibco) containing 25 mM HEPES
(Sigma) and 6.8 mM hypoxanthine (Sigma) supplemented with 10% AlbuMAX II (Invitrogen). The
culture medium was changed daily, and the culture was kept at 37°C in a mixture of 5% O , 3-5% CO ,
and N  environment. The in vitro evaluation of antimalarial activity in the erythrocyte stage of P.
falciparum was performed with synchronized cultures (with sorbitol 5%) in ring-stage parasites, under
different concentrations of the studied extracts and fractions, using the same culture without additional
compounds as control. The antimalarial activity of the compounds was determined by a fluorometric assay
using SYBR Green;[20] briefly, stock solutions of the samples were prepared in DMSO, and were diluted
to give a series of concentrations ranging from 3.9 to 250 µg/mL. 50 µL of each test concentration,
together with 50 µl of a 1% red blood parasitized cell suspension with ring stages and 2% hematocrit, were
distributed, in triplicate, into each of the 96-well plates and incubated for 48 h at 37°C. Next, 100 µl of
lysis buffer (Tris 20 mM; pH 7.5, EDTA 5 mM, saponin - 0.008%; wt/v, Triton X-100-0.08%; v/v)
containing SYBR Green at a concentration of 2 mg/mL were added to each microplate well. The plates
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measured in multiwell plate reader, Anthos venyth 3100 (Alfagene) with excitation and emission
wavelengths of 485 nm and 535 nm, respectively. Values were expressed in relative fluorescence units.
Analysis of the results obtained and IC  determination were performed with HN-NonLin V1.05 Beta
software.[21]
The conventional microtest method (Mark III),[22] based on evaluation of parasite development by optical
microscopy, were used as control of the selected fluorimetric method.
The selectivity index (SI), corresponding to the ratio between cytotoxic and antiparasitic activities, was
calculated as follows:
SI Plasmodium = (IC  HepG2)/(IC  Plasmodium).
RESULTS AND DISCUSSION
Antimalarial activity of extracts and fractions
An initial screening was performed on the four extracts listed in Table 1, in order to investigate the
cytotoxicity, in vitro antimalarial activity on the hepatic pre-erythrocytic stage of P. berghei and also,
against 3D7 chloroquine-sensitive and Dd2 chloroquine-resistant strains of P. falciparum. IC  values
were calculated from the set of seven concentrations tested for each extract.
Concerning the in vitro antimalarial activity against the liver stage of P. berghei (in Hep G2 cells), two of
the four extracts tested [Table 1] revealed good hepatic schizontocidal activity, with only the chloroform
extract of the root back having concentration below the respective IC  value for cytotoxicity. This latter
extract, CRBAa, showed the highest activity with an IC  value of 30.1 µg/mL, followed by the aqueous
extract of the root bark (AqRBAa, IC  = 39.9 µg/mL). The result obtained for the aqueous extract of the
root bark is comparable to that obtained by Andrade-Neto et al. (2008)[11] who tested the ethanol extract
of the root (28.8 µg/mL). Despite this similarity, this aqueous extract showed a higher cytotoxicity (17.50
µg/mL) probably due to the great amount of saponins in this extract,[6] when compared to the other
extracts analyzed.
The in vitro effect of the four extracts on the erythrocyte stage of P. falciparum was also tested, with
interesting results. As shown in Table 1, all the studied extracts presented weak activity, with the exception
of chloroform extract of A. amazonicus root bark (CRBAa), which exhibited the best antimalarial activity
against 3D7 and Dd2 strains of P. falciparum, with IC  values of 13.79 and 14.63 µg/mL, respectively.
The SI values observed for the most active extract, CRBAa, showed low selectivity (<5.0); however, these
values showed better selectivity for P. falciparum among the other studied extracts, with SI from 0.26 to
1.81 [Table 1].
This result was surprising because so far, the studies performed to verify the activity of the root extracts on
the blood stage of the cycle of malaria have been negative.[8,11] In addition, these data showed the
importance of extract preparation with solvents of different polarities, with fewer constituents than a crude
ethanol or aqueous extract, for optimum evaluation of the pharmacological activity associated with the
popular use of any botanical species. In this context, using the methodology for preparation of the extracts
described above, results hitherto not described for A. amazonicus were observed, such as active extracts
enriched with a mixture of closely related substances of similar polarities, diluted in a less complex matrix
of phytocompounds.
In order to identify the constituents responsible for the activity observed, the CRBAa extract was
fractionated as mentioned in materials and methods, and the isolated compounds were tested against 3D7
chloroquine-sensitive and Dd2 chloroquine-resistant P. falciparum strains. The structures of lupeol,
betulinic acid, betulin and melaleucic acid were elucidated based on NMR and MS analyzes, and by
comparison with the literature data. Previous studies mentioned the presence of pentacyclic triterpenes,
such as betulinic acid, betulin, and lupenone, in the roots of A. amazonicus.[23] Betulinic acid has shown a
wide range of biological activities, including leishmanicidal, trypanocidal and antiplasmodial.[24,25]
Melaleucic acid is a rare triterpene acid, whose isolation, so far, has been reported mainly for Melaleuca












(annonaceae)[27] and Heteropanax fragans (araliaceae).[28] Unlike betulinic acid, there have been no
studies on their pharmacological activity.
The activity of the isolated compounds is shown in Table 2. All the triterpenes, with the exception of
melaleucic acid, exhibited antiplasmodial activity against P. falciparum strains with IC  values ranging
from 5.6 to 80.30 µM. The most active compound was the naturally-occurring triterpene betulinic acid,
and these results corroborate those described in the literature for this substance.[25,29] The results found
for the active compounds, lupeol, and betulin, were also similar to those of other studies.[30,31]
Functional groups present in the structures of the triterpenes can be used to explain the different values of
activity found among the compounds,[25] and they can be used to explain the variation in IC  values of
the isolated triterpenes. Furthermore, the antimalarial activity of the betulinic acid, compared with other
triterpenes, suggests that the presence of the 3-β-hydroxyl and C-28 carboxyl groups is important for this
result.[29]
The most active triterpene, betulinic acid, was quantified in the CRBAa extract by HPLC-PAD, and the
results were compared with the IC  values found for each extract [Table 1]. For the chromatographic
analysis, experiments were carried out to optimize the mobile phase conditions in order to obtain the best
separation and resolution between betulinic acid and other constituents of the extracts. The isocratic
system with water: Acetonitrile (30:70, v/v) resulted in the chromatograms of the extract and betulinic acid
standard shown in Figure 1.
It was possible to identify betulinic acid in chloroform extract, with good separation within 20 min, under
the conditions described above. The concentration of this triterpene in the root bark chloroform extract was
300.85 µg/mL.
The hexane, ethanol, and aqueous extracts, which showed no significant antiplasmodial activity against
both P. falciparum strains, were also analyzed by HPLC-PAD, and with the exception of the hexane extract
(32.12 μg/mL of betulinic acid), the other did not present any detectable amount of betulinic acid in their
composition at the concentration studied and with the detector used. These results suggest that the amount
of betulinic acid may be important for the antiplasmodial activity of the extract. Recently, Quan et al.
(2013)[32] reported that betulinic acid can cause modifications of erythrocyte cholesterol-rich membrane
rafts, reduce hepatic steatosis, and be used to prevent fatty liver disease. Since these membrane rafts are
important for the entry of the malaria parasite to the host cells, according to our results, the extracts of A.
amazonicus enriched with betulinic acid could be promising for preventing and treating malaria, especially
taking into account that P. falciparum does not enter erythrocyte that is preloaded with this terpenoid.
CONCLUSION
As previously mentioned, A. amazonicus is used in folk medicine of the Amazon region to prevent malaria
and treat the symptoms of this disease. In this context, the results of this work demonstrated some
important facts, such as the blood stage antimalarial activity detected in chloroform extract and the
isolation of active triterpenes. Furthermore, the phytochemical methodology adopted in this work enabled
the highest activity to be concentrated in the chloroform extract, which led to an association between the
constituents of this plant with its antimalarial activity.
In conclusion, this study provides biological evidence that A. amazonicus has important antiplasmodial
activity, due to the presence of pentacyclic triterpenes. The results demonstrated that using different
extraction solvents of varying polarities was a good strategy for selecting chemical classes with
identifiable components, unlike the use of a crude extract. Two extracts of the root bark exhibited moderate
activity against the liver stage of P. berghei, with the chloroform of the root bark being the most active.
The hexane and chloroform extracts of the root bark, studied for their activities against erythrocyte stage of
P. falciparum in this work, were analyzed by HPLC-PAD, showing that the highest amount of betulinic
acid was in the chloroform extract, which also presented the highest bioactivity. Based on these premises,
it is clear that this is a complex and important plant species, and further studies are strongly recommended,
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Table 1
Biological activities of the extracts from Ampelozizyphus amazonicus
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Table 2
Antiplasmodial activity of isolated triterpenes from Ampelozizyphus amazonicus
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Figure 1
Open in a separate window
Comparative high-performance liquid chromatography chromatograms at 210 nm for (1) HRBAa (2) CRBAa and (3)
standard betulinic acid in the most active extracts
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